1. Academic Validation
  2. A neuronal cell-based reporter system for monitoring the activity of HDAC2

A neuronal cell-based reporter system for monitoring the activity of HDAC2

  • SLAS Discov. 2022 Oct 11;S2472-5552(22)13702-0. doi: 10.1016/j.slasd.2022.10.001.
Kazuhiro Unemura 1 Masako Kawano 2 Mai Takakura 2 Ikuko Iwata 2 Kana Hyakkoku 3 Naotaka Horiguchi 3 Tomohiko Okuda 4 Yukinori Hirano 5
Affiliations

Affiliations

  • 1 Medical innovation center, SK project, Kyoto University Graduate School of Medicine, Konoecho, Yoshida, Sakyo-ku, Kyoto, Kyoto 606-8315 Japan; Shionogi & Co., Ltd. Laboratory for Drug Discovery and Disease Research, Shionogi Pharmaceutical Research Center, 3-1-1, Futaba-cho, Toyonaka-shi, Osaka, 561-0825, Japan.
  • 2 Medical innovation center, SK project, Kyoto University Graduate School of Medicine, Konoecho, Yoshida, Sakyo-ku, Kyoto, Kyoto 606-8315 Japan.
  • 3 Shionogi & Co., Ltd. Laboratory for Drug Discovery and Disease Research, Shionogi Pharmaceutical Research Center, 3-1-1, Futaba-cho, Toyonaka-shi, Osaka, 561-0825, Japan.
  • 4 Shionogi & Co., Ltd. Laboratory for Bio-Drug Discovery, Shionogi Pharmaceutical Research Center, 3-1-1, Futaba-cho, Toyonaka-shi, Osaka, 561-0825, Japan.
  • 5 Medical innovation center, SK project, Kyoto University Graduate School of Medicine, Konoecho, Yoshida, Sakyo-ku, Kyoto, Kyoto 606-8315 Japan; Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China.
Abstract

Given that histone acetylation via histone acetyltransferases (HATs) and histone deacetylases (HDACs) is significant in memory formation, HDAC2 has been thoroughly investigated as a potential therapeutic target for the treatment of cognitive dysfunction. Although HDAC inhibitors have been discovered through in vitro Enzyme assay, off-target effects on other HDACs are common due to their conserved catalytic domains. Each HDAC could be regulated by specific intracellular molecular mechanisms, raising the possibility that a cell-based assay could identify selective inhibitors targeting specific HDACs through their regulatory mechanisms. Here, we propose a versatile, cell-based reporter system for screening HDAC2 inhibitors. Through RNA-sequencing from human cultured neuronal cells, we determined that expression of a transcriptional repressor, inhibitor of DNA binding 1 (ID1), is increased by knockdown of HDAC2. We also established the knock-in neuronal cell lines of a bioluminescence reporter gene to ID1. The knock-in cell lines showed significant reporter activity by known HDAC inhibitors and by HDAC2-knockdown but not by HDAC1-knockdown. Thus, our neuronal cell-based reporter system is a promising method for screening the specific inhibitors of HDAC2 but not HDAC1, by potentially targeting not only HDAC2, but also the regulatory mechanisms of HDAC2 in neurons.

Figures
Products